Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilfredo F Garcia-Beltran

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Nature Microbiology|September 22, 2025
A transatlantic joint lab model for interdisciplinary researchAngelique Hoelzemer, Wilfredo F Garcia-Beltran
Frontiers in Immunology|November 30, 2017
Natural Killer Cell Interactions with Classical and Non-Classical Human Leukocyte Antigen Class I in HIV-1 InfectionAngelique Hölzemer, Wilfredo F Garcia-Beltran, Marcus Altfeld
Scientific Reports|May 27, 2017
Peptide-specific engagement of the activating NK cell receptor KIR2DS1Anaïs Chapel, Wilfredo F Garcia-Beltran, Angelique Hölzemer, et al.
Advanced Functional Materials|March 19, 2013
Composite dissolving microneedles for coordinated control of antigen and adjuvant delivery kinetics in transcutaneous vaccinationPeter C Demuth, Wilfredo F Garcia-Beltran, Michelle Lim Ai-Ling, et al.
Plos One|December 19, 2015
Influence of Glycosylation Inhibition on the Binding of KIR3DL1 to HLA-B*57:01Wilhelm Salzberger, Wilfredo F Garcia-Beltran, Haley Dugan, et al.
Frontiers in Immunology|December 17, 2021
A Genome-Wide CRISPR/Cas9-Based Screen Identifies Heparan Sulfate Proteoglycans as Ligands of Killer-Cell Immunoglobulin-Like ReceptorsKlara Klein, Angelique Hölzemer, Tim Wang, et al.
Frontiers in Immunology|November 3, 2018
Stable Frequencies of HLA-C<sup>*</sup>03:04/Peptide-Binding KIR2DL2/3<sup>+</sup> Natural Killer Cells Following VaccinationMaja Christiane Ziegler, Ferran Borràs Grañana, Wilfredo F Garcia-Beltran, et al.
Plos Pathogens|June 24, 2022
HIV-1 Nef-mediated downregulation of CD155 results in viral restriction by KIR2DL5+ NK cellsPia Fittje, Angelique Hœlzemer, Wilfredo F Garcia-Beltran, et al.
Retrovirology|July 23, 2013
Dysregulated Tim-3 expression on natural killer cells is associated with increased Galectin-9 levels in HIV-1 infectionStephanie Jost, Uriel Y Moreno-Nieves, Wilfredo F Garcia-Beltran, et al.
Expert Opinion on Biological Therapy|May 11, 2026
Next-generation CAR-NK cell therapy for glioblastoma: strategies to overcome antigen escape and the immunosuppressive tumor microenvironmentSamuel J Steuart, Eric P Grewal, Jing Sun, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Nature Microbiology|September 22, 2025
A transatlantic joint lab model for interdisciplinary researchAngelique Hoelzemer, Wilfredo F Garcia-Beltran
Frontiers in Immunology|November 30, 2017
Natural Killer Cell Interactions with Classical and Non-Classical Human Leukocyte Antigen Class I in HIV-1 InfectionAngelique Hölzemer, Wilfredo F Garcia-Beltran, Marcus Altfeld
Scientific Reports|May 27, 2017
Peptide-specific engagement of the activating NK cell receptor KIR2DS1Anaïs Chapel, Wilfredo F Garcia-Beltran, Angelique Hölzemer, et al.
Advanced Functional Materials|March 19, 2013
Composite dissolving microneedles for coordinated control of antigen and adjuvant delivery kinetics in transcutaneous vaccinationPeter C Demuth, Wilfredo F Garcia-Beltran, Michelle Lim Ai-Ling, et al.
Plos One|December 19, 2015
Influence of Glycosylation Inhibition on the Binding of KIR3DL1 to HLA-B*57:01Wilhelm Salzberger, Wilfredo F Garcia-Beltran, Haley Dugan, et al.
Frontiers in Immunology|December 17, 2021
A Genome-Wide CRISPR/Cas9-Based Screen Identifies Heparan Sulfate Proteoglycans as Ligands of Killer-Cell Immunoglobulin-Like ReceptorsKlara Klein, Angelique Hölzemer, Tim Wang, et al.
Frontiers in Immunology|November 3, 2018
Stable Frequencies of HLA-C<sup>*</sup>03:04/Peptide-Binding KIR2DL2/3<sup>+</sup> Natural Killer Cells Following VaccinationMaja Christiane Ziegler, Ferran Borràs Grañana, Wilfredo F Garcia-Beltran, et al.
Plos Pathogens|June 24, 2022
HIV-1 Nef-mediated downregulation of CD155 results in viral restriction by KIR2DL5+ NK cellsPia Fittje, Angelique Hœlzemer, Wilfredo F Garcia-Beltran, et al.
Retrovirology|July 23, 2013
Dysregulated Tim-3 expression on natural killer cells is associated with increased Galectin-9 levels in HIV-1 infectionStephanie Jost, Uriel Y Moreno-Nieves, Wilfredo F Garcia-Beltran, et al.
Expert Opinion on Biological Therapy|May 11, 2026
Next-generation CAR-NK cell therapy for glioblastoma: strategies to overcome antigen escape and the immunosuppressive tumor microenvironmentSamuel J Steuart, Eric P Grewal, Jing Sun, et al.
Pageof 6